Kymera Therapeutics (KYMR) Return on Sales (2019 - 2026)
Kymera Therapeutics (KYMR) posted quarterly Return on Sales of 0.14% for Q1 2026, down 6.0% year-over-year from 0.15% in Q1 2025, and up 57.79% quarter-over-quarter from 0.34% in Q4 2025.
Kymera Therapeutics (KYMR) Return on Sales (2019 - 2026) Analysis & Trends
Kymera Therapeutics (KYMR) has reported Return on Sales for 8 consecutive years, with 0.14% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales fell 6.0% year-over-year to 0.14%; the TTM figure through Mar 2026 stood at 0.22% (down 12.0% YoY), while the FY2025 annual figure was 0.19%, down 9.0% from the prior year.
- Return on Sales advanced to 0.14% in Q1 2026 per KYMR's latest filing, from 0.34% in the prior quarter.
- Across five years, Return on Sales topped out at 0.01% in Q4 2023 and bottomed at 1.24% in Q3 2025.
- Historically, Return on Sales has averaged 0.23% across 5 years, with a median of 0.12% in 2023.
- On a YoY basis, Return on Sales climbed as much as 9 bps in 2025 and fell as far as 65 bps in 2025.
- Kymera Therapeutics' Return on Sales stood at 0.02% in 2022, then jumped by 40 bps to 0.01% in 2023, then sank by 659 bps to 0.11% in 2024, then plunged by 212 bps to 0.34% in 2025, then jumped by 58 bps to 0.14% in 2026.
- Business Quant data shows KYMR's Return on Sales at 0.14% in Q1 2026, 0.34% in Q4 2025, and 1.24% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Kymera Therapeutics | 9.72 Bn | 9.03 Bn | - | -0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11% |
| Mar 31, 2026 | -0.14% |
| Dec 31, 2025 | -0.34% |
| Sep 30, 2025 | -1.24% |
| Jun 30, 2025 | -0.19% |
| Mar 31, 2025 | -0.09% |
| Dec 31, 2024 | -0.11% |
| Sep 30, 2024 | -0.59% |
| Jun 30, 2024 | -0.04% |
| Mar 31, 2024 | -0.18% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.39% |
| Jun 30, 2023 | -0.10% |
| Mar 31, 2023 | -0.12% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.10% |
| Jun 30, 2022 | -0.07% |
| Mar 31, 2022 | -0.18% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.13% |